Potentiation of a monoamine oxidase inhibitor by tryptophan
- 31 December 1969
- journal article
- clinical trial
- Published by Elsevier in Journal of Psychiatric Research
- Vol. 7 (2) , 83-88
- https://doi.org/10.1016/0022-3956(69)90013-2
Abstract
No abstract availableThis publication has 19 references indexed in Scilit:
- NORADRENALINE, 5-HYDROXYTRYPTAMINE, AND 5-HYDROXYINDOLEACETIC ACID IN HINDBRAINS OF SUICIDAL PATIENTSThe Lancet, 1968
- 5-Hydroxytryptamine in the Hind-Brain of Depressive SuicidesThe British Journal of Psychiatry, 1967
- 5-HYDROXYINDOLE COMPOUNDS IN THE CEREBROSPINAL FLUID OF PATIENTS WITH PSYCHIATRIC OR NEUROLOGICAL DISEASESThe Lancet, 1966
- Tryptamine Metabolism in DepressionThe British Journal of Psychiatry, 1965
- FURTHER STUDIES ON: ONE DAY TREATMENT OF DEPRESSION WITH 5-HTPAmerican Journal of Psychiatry, 1964
- Clinical experience with dihydroxyphenylalanine (DOPA) in depressionJournal of Psychiatric Research, 1963
- POTENTIATION OF MONOAMINE-OXIDASE INHIBITORS BY TRYPTOPHANThe Lancet, 1963
- POTENTIATION OF THE ANTIDEPRESSIVE EFFECT OF A MONOAMINE-OXIDASE INHIBITOR BY TRYPTOPHANThe Lancet, 1963
- 5-Hydroxyindoles in Human Cerebrospinal FluidsNature, 1960
- A CLINICAL AND BIOCHEMICAL STUDY OF A TRIAL OF IPRONIAZID IN THE TREATMENT OF DEPRESSIONJournal of Neurology, Neurosurgery & Psychiatry, 1959